What is NEPH (NEPH) stock price today?

NEPH (NEPH) is currently trading at $4.21, up 19.6% today.

What is NEPH P/E ratio?

NEPH's P/E ratio is 28.45. This is near the market average.

What is NEPH return on equity (ROE)?

NEPH's return on equity (ROE) is 10.00%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is NEPH's market cap?

NEPH has a market capitalization of $45.71M.

NASDAQ · Medical - Instruments & Supplies

NEPH (NEPH) Stock

$4.21 +19.60% NASDAQ: NEPH Healthcare

Valuation

Metric	Value
Price	$4.21
Market Cap	$45.71M
P/E Ratio	28.45
P/B Ratio	3.40
P/S Ratio	2.09
EPS (TTM)	$0.11
52-Week High	$6.42
52-Week Low	$2.66
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	10.00%
ROA	7.14%
ROCE	9.09%
Gross Margin	5.26%
Operating Margin	5.26%
Net Margin	4.06%
Debt/Equity	0.09
Current Ratio	3.67

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$10.0M	$10.0M	$14.0M	$14.0M	$19.0M
Operating Profit	$-3.0M	$-4.0M	$-2.0M	$0	$1.0M
Net Profit	$-4.0M	$-7.0M	$-2.0M	$0	$1.0M
EPS	$-0.41	$-0.72	$-0.15	$0.01	$0.11
Op Margin	-31.8%	-43.5%	-11.2%	0.0%	6.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$18.0M	$11.0M	$12.0M	$11.0M	$14.0M
Total Liabilities	$3.0M	$2.0M	$4.0M	$3.0M	$3.0M
Cash	$7.0M	$4.0M	$4.0M	$4.0M	$5.0M
Borrowings	$1.0M	$1.0M	$2.0M	$1.0M	$1.0M

Latest News

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET GlobeNewswire · Jul 20, 2026 Northland Securities Initiates Coverage on Nephros With Market Perform Rating, $4 Price Target MT Newswires · Jul 17, 2026 Nephros Announces Inclusion in the Russell Microcap® Index GlobeNewswire · Jul 6, 2026 Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action” GlobeNewswire · Jun 18, 2026 Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water GlobeNewswire · Jun 16, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-3.0M	$1.0M	$0	$2.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-1.0M	$-3.0M	$1.0M	$-1.0M	$2.0M
Free Cash Flow	$-1.0M	$-3.0M	$1.0M	$-1.0M	$2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	29.98
FCF Yield	-0.87%
Quick Ratio	3.12
Interest Coverage	—
Return 1Y	3.68%
Return 3Y	161.43%
Return 5Y	-59.24%

Ownership

Insiders Held12.87%

Institutions Held49.09%

Institutions Float Held56.34%

Institutional Holder	Shares	Report Date
Wexford Capital LP	3,600,552	2026-03-31
Topline Capital Management, LLC	581,967	2026-03-31
Vanguard Capital Management LLC	198,643	2026-03-31
Cornerstone Capital, Inc.	128,700	2026-03-31
Bard Associates Inc.	121,202	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BEAT	$0.50	+0.98%	-1.48	$17.10M	0.00%
DXRDaxor Corporation	$10.71	+2.24%	5.90	$53.94M	0.00%
HOWL	$0.40	-3.04%	-0.33	$19.54M	0.00%
ICCC	$10.75	-2.89%	-82.33	$97.25M	0.00%
NRXPNRx Pharmaceuticals, Inc.	$3.66	-2.40%	-2.92	$63.27M	0.00%

About NEPH

NEPH is led by CEO Robert Banks, employs 31 people, headquartered in US, publicly traded since 2004.

NEPH stock trades at $4.21 with a market capitalization of $45.71M. The stock is valued at a price-to-earnings (P/E) ratio of 28.45, price-to-book of 3.40, price-to-sales of 2.09. Over the past 52 weeks the stock has ranged between $2.66 and $6.42, and currently trades 34.4% below its 52-week high.

On profitability, NEPH generates a return on equity (ROE) of 10.00%, return on capital employed of 9.09%, an operating margin of 5.26%, a net profit margin of 4.06%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides